Target intelligence / Profile preview

UBE2F pseudogene 3 (UBE2FP3)

Target
UBE2FP3
Molecular classification
Other (Pseudogene)
01

Overview

UBE2FP3 is classified as a pseudogene of the ubiquitin-conjugating enzyme E2 F family, meaning it is a non-functional genetic element that does not produce an active protein product. As such, it has no known role in protein function, biological pathways, or disease processes, unlike its functional counterpart UBE2F. UBE2FP3 is not considered a therapeutic target and does not serve as an actionable or druggable biomolecule in any known context. Pseudogenes do not have well-defined biological functions. The functional gene UBE2F is involved in protein neddylation, but UBE2FP3 does not encode a functional product. No validated disease role for UBE2FP3. Disease associations pertain to the functional UBE2F gene, not to UBE2FP3. The functional E2 F gene (UBE2F) is sometimes overexpressed in cancers and has roles in protein neddylation and related signaling; however, UBE2FP3 does not share these functional properties. There is no evidence from any major human genomic or therapeutic database that UBE2FP3 serves as a molecular drug target, receptor, enzyme, diagnostic marker, or therapeutic concern.

Other names
ubiquitin conjugating enzyme E2F (putative) pseudogene 3ubiquitin conjugating enzyme E2 F (putative) pseudogene 3UBE2FP3

Beyond the preview

Go deeper on UBE2F pseudogene 3 (UBE2FP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBE2F pseudogene 3 (UBE2FP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call